FDA device listing
Dexcom G6 Continuous Glucose Monitoring System
FDA device listing 2003286583 · PLEXUS CORP.
Key facts
| Proprietary names | Dexcom G6 Continuous Glucose Monitoring System |
|---|---|
| Owner/operator | PLEXUS CORP. |
| Owner/operator number | 3019588 |
| Product codes | QBJ |
| Device names | QBJ - Integrated Continuous Glucose Monitoring System, Factory Calibrated |
| Device class | Class II |
| Classification regulations (21 CFR) | 862.1355 |
| Review panels | Clinical Chemistry |
| Registered establishments | Plexus Electronica S. de R.L. de C.V.. |
| Establishment registrations | 3011120183 |
| FEI numbers | 3011120183 |
| Establishment operations | Contract Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database